SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 103 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,369,000 | +2.2% | 2,499,581 | +0.9% | 0.00% | – |
| Q1 2016 | $1,339,000 | -30.4% | 2,478,372 | +15.7% | 0.00% | – |
| Q4 2015 | $1,923,000 | +17.9% | 2,142,511 | +6.4% | 0.00% | – |
| Q3 2015 | $1,631,000 | -68.6% | 2,013,821 | +16.8% | 0.00% | – |
| Q2 2015 | $5,190,000 | +23.2% | 1,724,242 | +0.3% | 0.00% | – |
| Q1 2015 | $4,212,000 | +2.5% | 1,719,290 | +6.7% | 0.00% | – |
| Q4 2014 | $4,110,000 | -60.5% | 1,611,555 | +10.6% | 0.00% | -100.0% |
| Q3 2014 | $10,403,000 | +20.5% | 1,456,988 | +10.0% | 0.00% | 0.0% |
| Q2 2014 | $8,636,000 | +3.7% | 1,324,475 | +5.2% | 0.00% | 0.0% |
| Q1 2014 | $8,325,000 | +64.6% | 1,259,443 | +18.1% | 0.00% | – |
| Q4 2013 | $5,057,000 | +6.8% | 1,066,814 | +11.8% | 0.00% | – |
| Q3 2013 | $4,733,000 | -4.6% | 954,241 | +0.2% | 0.00% | -100.0% |
| Q2 2013 | $4,960,000 | – | 951,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |